P Algara

1.2k total citations
19 papers, 721 citations indexed

About

P Algara is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, P Algara has authored 19 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 9 papers in Genetics and 6 papers in Oncology. Recurrent topics in P Algara's work include Lymphoma Diagnosis and Treatment (15 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Genetic factors in colorectal cancer (4 papers). P Algara is often cited by papers focused on Lymphoma Diagnosis and Treatment (15 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Genetic factors in colorectal cancer (4 papers). P Algara collaborates with scholars based in Spain, United Kingdom and Cuba. P Algara's co-authors include Miguel Á. Piris, Manuela Mollejo, E. Lloret, Raquel Villuendas, Javier Menárguez, Eva Cristóbal, Margarita Sánchez‐Beato, Elı́as Campo, Pedro Martı́nez and L Sánchez‐Verde and has published in prestigious journals such as Blood, The American Journal of Surgical Pathology and The Journal of Pathology.

In The Last Decade

P Algara

19 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Algara Spain 14 572 352 338 89 86 19 721
J.-i. Tamaru Japan 10 647 1.1× 305 0.9× 553 1.6× 88 1.0× 161 1.9× 12 898
Carmen Pedro Spain 15 413 0.7× 314 0.9× 301 0.9× 126 1.4× 47 0.5× 27 885
Flora N. Kontopidou Greece 17 427 0.7× 255 0.7× 216 0.6× 112 1.3× 82 1.0× 37 615
TC Greiner United States 8 709 1.2× 317 0.9× 454 1.3× 176 2.0× 111 1.3× 10 824
Paul‐André Bryon France 14 509 0.9× 265 0.8× 338 1.0× 91 1.0× 150 1.7× 18 687
Joan H. Admirand United States 17 413 0.7× 294 0.8× 270 0.8× 195 2.2× 46 0.5× 23 749
James T. Sundeen United States 12 554 1.0× 246 0.7× 330 1.0× 240 2.7× 74 0.9× 15 804
Christina Kalpadakis Greece 17 413 0.7× 311 0.9× 235 0.7× 107 1.2× 99 1.2× 48 727
Audrey Sylvia Baur Switzerland 12 417 0.7× 222 0.6× 292 0.9× 107 1.2× 77 0.9× 15 716
CR Kjeldsberg United States 11 511 0.9× 229 0.7× 340 1.0× 76 0.9× 94 1.1× 23 713

Countries citing papers authored by P Algara

Since Specialization
Citations

This map shows the geographic impact of P Algara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Algara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Algara more than expected).

Fields of papers citing papers by P Algara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Algara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Algara. The network helps show where P Algara may publish in the future.

Co-authorship network of co-authors of P Algara

This figure shows the co-authorship network connecting the top 25 collaborators of P Algara. A scholar is included among the top collaborators of P Algara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Algara. P Algara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kanellis, G., Manuela Mollejo, Santiago Montes‐Moreno, et al.. (2010). Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features. Haematologica. 95(7). 1122–1129. 53 indexed citations
2.
Tracey, Lorraine, Mónica García‐Cosío, Raquel Villuendas, et al.. (2008). Somatic hypermutation signature in B-cell low-grade lymphomas. Haematologica. 93(8). 1186–1194. 8 indexed citations
3.
Fuente, Enrique Gómez de la, Pablo L. Ortiz‐Romero, F. Vanaclocha, et al.. (2003). Factores clínicos y analíticos de progresión y supervivencia en linfomas cutáneos de células T (micosis fungoide/síndrome de Sézary). Actas Dermo-Sifiliográficas. 94(6). 356–367. 1 indexed citations
4.
Mollejo, Manuela, P Algara, M. Sol Mateo, et al.. (2002). Splenic small B‐cell lymphoma with predominant red pulp involvement: a diffuse variant of splenic marginal zone lymphoma?. Histopathology. 40(1). 22–30. 53 indexed citations
5.
6.
Rodríguez‐­Peralto, José Luis, Manuel Martínez, P Algara, et al.. (2001). Primary Cutaneous Large B-Cell Lymphoma. The American Journal of Surgical Pathology. 25(3). 307–315. 27 indexed citations
7.
Lloret, E., et al.. (1999). Splenic marginal zone lymphoma with increased number of blasts: An aggressive variant?. Human Pathology. 30(10). 1153–1160. 40 indexed citations
8.
Garcı́a, Juan F., Raquel Villuendas, P Algara, et al.. (1999). Loss of p16 protein expression associated with methylation of the p16INK4A gene is a frequent finding in Hodgkin's disease.. PubMed. 79(12). 1453–9. 34 indexed citations
9.
Mateo, M. Sol, Manuela Mollejo, Raquel Villuendas, et al.. (1998). Analysis of the frequency of microsatellite instability and p53 gene mutation in splenic marginal zone and MALT lymphomas.. Molecular Pathology. 51(5). 262–267. 28 indexed citations
10.
Villuendas, Raquel, Francesco Pezzella, Kevin C. Gatter, et al.. (1997). p21WAF1CIP1 AND MDM2 EXPRESSION IN NON‐HODGKIN'S LYMPHOMA AND THEIR RELATIONSHIP TO p53 STATUS: A p53+, MDM2−, p21− IMMUNOPHENOTYPE ASSOCIATED WITH MISSENSE p53 MUTATIONS. The Journal of Pathology. 181(1). 51–61. 1 indexed citations
11.
Villuendas, Raquel, Francesco Pezzella, Kevin C. Gatter, et al.. (1997). p21WAF1/CIP1 AND MDM2 EXPRESSION IN NON-HODGKIN'S LYMPHOMA AND THEIR RELATIONSHIP TO p53 STATUS: A p53+, MDM2−, p21− IMMUNOPHENOTYPE ASSOCIATED WITH MISSENSE p53 MUTATIONS. The Journal of Pathology. 181(1). 51–61. 60 indexed citations
12.
García‐Sánchez, F., Javier Menárguez, Eva Cristóbal, et al.. (1995). Hepatosplenic gamma‐delta T‐cell malignant lymphoma: report of the first case in childhood, including molecular minimal residual disease follow‐up. British Journal of Haematology. 90(4). 943–946. 32 indexed citations
13.
Mollejo, Manuela, Javier Menárguez, E. Lloret, et al.. (1995). Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases.. PubMed. 19(10). 1146–57. 112 indexed citations
14.
Mollejo, Manuela, Javier Menárguez, E. Lloret, et al.. (1995). A Clinicopathological Study of 13 Cases. The American Journal of Surgical Pathology. 19(10). 1146–1157. 87 indexed citations
15.
Mollejo, Manuela, Javier Menárguez, Eva Cristóbal, et al.. (1994). Monocytoid B cells. A comparative clinical pathological study of their distribution in different types of low-grade lymphomas.. PubMed. 18(11). 1131–9. 27 indexed citations
16.
Sánchez, Lara M. Munín, P Algara, Raquel Villuendas, et al.. (1993). B-cell clonal detection in gastric low-grade lymphomas and regional lymph nodes: an immunohistologic and molecular study.. PubMed. 88(3). 413–9. 4 indexed citations
17.
Villuendas, Raquel, et al.. (1993). The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations. Blood. 82(10). 3151–3156. 8 indexed citations
18.
Villuendas, Raquel, et al.. (1993). The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations. Blood. 82(10). 3151–3156. 91 indexed citations
19.
Soria, C., et al.. (1992). True Histiocytic Lymphoma (Monocytic Sarcoma). American Journal of Dermatopathology. 14(6). 511–517. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026